The CRC risk in individuals affected by LS is variable depending on the MMR gene in which the mutation is located, with an earlier age of onset for mutation carriers in MLH1 or MSH2 genes compared to carriers in MSH6 or PMS2 (7). Here, MRC1 is linked to colorectal carcinoma.